Radhakrishnan Ramchandren Selected Research

Janus Kinase 1

1/2019

Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Radhakrishnan Ramchandren Research Topics

Disease

22	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 06/2012
9	Neoplasms (Cancer) 01/2021 - 12/2013
5	Disease Progression 02/2023 - 10/2013
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2023 - 01/2019
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2021 - 10/2013
4	Neutropenia 01/2021 - 01/2018
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2017 - 06/2012
3	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021 - 01/2020
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 03/2014
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2020 - 12/2014
2	Febrile Neutropenia 01/2022 - 01/2018
2	Pneumonia (Pneumonitis) 01/2021 - 02/2019
2	Lymphoma (Lymphomas) 01/2020 - 06/2012
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2020 - 01/2020
2	Hematologic Neoplasms (Hematological Malignancy) 03/2014 - 08/2013
1	Amyloidosis 11/2023
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Nausea 12/2021
1	Hepatitis 01/2020
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2020
1	Chemical and Drug Induced Liver Injury 01/2020
1	Anemia 10/2019
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2019
1	Exanthema (Rash) 10/2019
1	Acute Kidney Injury (Acute Renal Failure) 02/2019
1	Sepsis (Septicemia) 01/2019
1	Respiratory Insufficiency (Respiratory Failure) 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2014
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2009

Drug/Important Bio-Agent (IBA)

18	Brentuximab VedotinIBA 01/2022 - 06/2012
6	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 08/2013
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2018
5	Rituximab (Mabthera)FDA Link 02/2023 - 01/2018
5	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 01/2018
5	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022 - 01/2018
5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2018
4	ibrutinibIBA 02/2023 - 01/2019
4	Lenalidomide (CC 5013)FDA Link 02/2023 - 10/2013
4	NivolumabIBA 12/2021 - 01/2018
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 01/2018
2	pembrolizumabIBA 01/2022 - 01/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 10/2019
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2020
2	Monoclonal AntibodiesIBA 01/2021 - 10/2019
2	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2020 - 02/2019
2	Ifosfamide FDA LinkGeneric 01/2020 - 01/2019
2	LigandsIBA 10/2018 - 01/2018
1	Amyloid (Amyloid Fibrils)IBA 11/2023
1	Prealbumin (Transthyretin)IBA 11/2023
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2023
1	Iodine-124IBA 11/2023
1	Peptides (Polypeptides)IBA 11/2023
1	venetoclaxIBA 10/2021
1	fimepinostatIBA 10/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	durvalumabIBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	PlatinumIBA 01/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	tributyl phosphate (TBP)IBA 01/2020
1	urelumabIBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020
1	Aurora Kinase AIBA 10/2019
1	MLN 8237IBA 10/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Aspartic Acid (Aspartate)FDA Link 01/2019
1	itacitinibIBA 01/2019
1	parsaclisibIBA 01/2019
1	Janus Kinase 1IBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	Lipase (Acid Lipase)FDA Link 10/2018
1	Inotuzumab OzogamicinIBA 01/2018
1	B7-H1 AntigenIBA 01/2018
1	Everolimus FDA Link 01/2018
1	Bortezomib (Velcade)FDA Link 10/2013
1	Imatinib Mesylate (Gleevec)FDA Link 01/2009
1	Dasatinib (BMS 354825)FDA Link 01/2009

Therapy/Procedure

14	Therapeutics 01/2022 - 01/2009
9	Stem Cell Transplantation 02/2023 - 06/2012
9	Drug Therapy (Chemotherapy) 06/2021 - 01/2018
3	Salvage Therapy 12/2021 - 01/2018
1	Intravenous Infusions 11/2023
1	Transplantation 01/2022
1	Homologous Transplantation 01/2021
1	Nephrectomy 02/2019
1	Cell Transplantation 10/2018
1	Intravenous Administration 01/2016
1	Retreatment 03/2014